Mordmüller, Benjamin https://orcid.org/0000-0001-9101-2768
Sulyok, Zita
Sulyok, Mihály
Molnar, Zsofia
Lalremruata, Albert https://orcid.org/0000-0002-4692-7835
Calle, Carlos Lamsfus https://orcid.org/0000-0002-6766-1765
Bayon, Patricia Granados
Esen, Meral
Gmeiner, Markus
Held, Jana
Heimann, Henri-Lynn
Woldearegai, Tamirat Gebru https://orcid.org/0000-0001-9508-1787
Ibáñez, Javier https://orcid.org/0000-0001-6215-6332
Flügge, Judith
Fendel, Rolf https://orcid.org/0000-0003-4716-0311
Kreidenweiss, Andrea
KC, Natasha
Murshedkar, Tooba
Chakravarty, Sumana
Riyahi, Pouria
Billingsley, Peter F.
Church, L. W. Preston
Richie, Thomas L. https://orcid.org/0000-0002-2946-5456
Sim, B. Kim Lee
Hoffman, Stephen L. https://orcid.org/0000-0002-0700-9505
Kremsner, Peter G. https://orcid.org/0000-0002-3926-4113
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R44AI055229, 5R44AI058375)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Deutsches Zentrum für Infektionsforschung (TTU 03.902, TTU 03.902)
Article History
Received: 19 October 2021
Accepted: 24 June 2022
First Online: 23 August 2022
Competing interests
: NKC, SC, PR, LWPC, TLR, BKLS, and SLH are salaried, full-time employees of Sanaria, the developer and sponsor of Sanaria PfSPZ Vaccine and PfSPZ Challenge. SLH and BKLS also have financial interests in Sanaria. BKLS and SLH are inventors on patents and patent applications that have been assigned to Sanaria. BM and PGK received funding from DZIF to conduct the trial. All other authors declare no competing interests.